Skip to content

Pharmacy

CHPA issues statement on OTC eligibility in FSA/HSA accounts

CHPA issues statement on OTC eligibility in FSA/HSA accounts

The Consumer Healthcare Products Association (CHPA) issued the following statement regarding OTC Eligibility in FSA/HSA Accounts: “CHPA congratulates Representatives Lynn Jenkins (R, Kan.), Ron Kind (D, Wis.), and Grace Meng (D, N.Y.) on the House of Representatives’ passage of H.R.

HDA issues statement on FDA to examine prescription drug importation

HDA issues statement on FDA to examine prescription drug importation

Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policie

Innovus Pharma enters into pilot program with CVS Pharmacy

Innovus Pharma enters into pilot program with CVS Pharmacy

Innovus Pharmaceuticals, Inc. announced that it has entered into a pilot program with the nationwide pharmaceutical chain CVS Pharmacy to sell the company’s product Androferti, to increase sperm quality. The CVS men’s health in-store clinic pilot program will promote Androferti in 12 to 20 stores.

PCMA issues statement on FDA biosimilar action plan

PCMA issues statement on FDA biosimilar action plan

Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on the Food and Drug Administration’s (FDA) new Biosimilars Action Plan: “We applaud the FDA for taking important steps toward approving more biosimilars in the Unite

House passes OTC Monograph Reform Legislation

House passes OTC Monograph Reform Legislation

The U.S. House of Representatives has passed H.R. 5333, the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 – bipartisan legislation sponsored by Representatives Bob Latta (R, Ohio), Diana DeGette (D, Colo.